Test
Formulation: Liquid. In 0.05M glycine, pH 9 with <0.1% CHAPS and <0.01% SDS. Source: Isolated from A-72 cells/Virus strain 1-71. Long Term Storage: -20°C. Applications: ELISA .
Coagulation Factor VIII Human, Native Protein is purified from human plasma. The protein contains 2332 amino acids and has a molecular mass of 330 kDa. The protein is purified by proprietary chromatographic techniques. FORMULATION: Sterile-filtered white lyophilized (freeze-dried) powder. The protein is lyophilized from a 200 IU/ml sterile solution containing 1.5% Glycine, 160 mM Calcium chloride and 25 mM NaCitrate and 25 mM NaCl. BIOLOGICAL ACTIVITY: 10 Units/mg. VIRAL TESTING: The plasma is collected from donors vaccinated against Hepatitis B. Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O and Anti-HCV with FDA approved methods. OTHER NAMES: Coagulation factor-VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein.
Coagulation Factor VIII Human, Native Protein is purified from human plasma. The protein contains 2332 amino acids and has a molecular mass of 330 kDa. The protein is purified by proprietary chromatographic techniques. FORMULATION: Sterile-filtered white lyophilized (freeze-dried) powder. The protein is lyophilized from a 200 IU/ml sterile solution containing 1.5% Glycine, 160 mM Calcium chloride and 25 mM NaCitrate and 25 mM NaCl. BIOLOGICAL ACTIVITY: 10 Units/mg. VIRAL TESTING: The plasma is collected from donors vaccinated against Hepatitis B. Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O and Anti-HCV with FDA approved methods. OTHER NAMES: Coagulation factor-VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein.
Coagulation Factor VIII Human, Native Protein is purified from human plasma. The protein contains 2332 amino acids and has a molecular mass of 330 kDa. The protein is purified by proprietary chromatographic techniques. FORMULATION: Sterile-filtered white lyophilized (freeze-dried) powder. The protein is lyophilized from a 200 IU/ml sterile solution containing 1.5% Glycine, 160 mM Calcium chloride and 25 mM NaCitrate and 25 mM NaCl. BIOLOGICAL ACTIVITY: 10 Units/mg. VIRAL TESTING: The plasma is collected from donors vaccinated against Hepatitis B. Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O and Anti-HCV with FDA approved methods. OTHER NAMES: Coagulation factor-VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein.